Uniphar records strong profit growth of over 6% driven by pharma division

Uniphar is headquartered in Dublin

Uniphar chief executive Ger Rabbette said the group remains confident of achieving their target of €200m earnings before interest, taxes, depreciation, and amortisation by 2028.

Healthcare services firm Uniphar has seen its revenue and profit increase over the first six months of this year driven by strong growth in its pharma division.

In the six-month period, it generated revenue of nearly €1.49bn - up 8.6% compared to the same period in 2024. Its gross profit stood at €219.65m, an increase of 6.3%.